Jefferies Financial Group Reaffirms “Buy” Rating for Target Healthcare REIT (LON:THRL)

Target Healthcare REIT (LON:THRL – Get Free Report)‘s stock had its “buy” rating reaffirmed by Jefferies Financial Group in a research report issued on Thursday, Digital Look reports. They presently have a GBX 124 target price on the stock. Jefferies Financial Group’s price objective points to a potential upside of 7.83% from the company’s previous close.

Target Healthcare REIT Price Performance

LON THRL opened at GBX 115 on Thursday. The company has a market cap of £713.27 million, a price-to-earnings ratio of 8.63, a PEG ratio of 1.48 and a beta of 0.71. The stock’s fifty day moving average price is GBX 111.87 and its 200 day moving average price is GBX 109.06. Target Healthcare REIT has a 1 year low of GBX 92 and a 1 year high of GBX 117.

Target Healthcare REIT (LON:THRL – Get Free Report) last announced its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. Research analysts expect that Target Healthcare REIT will post 6.22 earnings per share for the current year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Further Reading

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.